Loading...

PODCAST

This Week In Medicine

Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered!Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you.Each episode offers a filtered and concentrated summary of key journal

health & fitness medicine

All Episodes

1:24

JAMA 9 2026Intrauterine Mepivacaine Instillation vs...

This Week In Medicine ·

2026/09/24

This clinical study investigates whether applying a local anesthetic directly into the uterus can alleviate the discomfort typically associated with IUD insertion for women who have never given birth. By comparing the effects of mepivacaine against a saltwater placebo, researchers discovered that the medication significantly lowered pain scores and improved the overall tolerability of the procedure. These findings are vital because reducing physical distress can enhance patient autonomy and

en-US

1:43

JAMA 9 2026 Medicare Advantage Enrollment and Access...

This Week In Medicine ·

2026/09/24

This retrospective study evaluates whether the expansion of Medicare Advantage eligibility for patients with end-stage kidney disease has impacted their ability to receive life-saving treatments. By comparing data from 2021 through 2023, researchers discovered that those enrolled in private Medicare Advantage plans faced significantly lower rates of kidney transplantation and new wait-listing compared to those in traditional Medicare. These disparities were most pronounced among younger

en-US

1:39

JAMA 9 2026 Tenecteplase Before Thrombectomy at 4.5...

This Week In Medicine ·

2026/09/24

This clinical study investigated whether administering the clot-busting drug tenecteplase prior to a surgical thrombectomy would benefit patients experiencing a severe stroke in the back of the brain. Researchers focused specifically on individuals who arrived at the hospital in a late time window, between 4.5 and 24 hours after their symptoms began. The trial discovered that adding the medication did not lead to higher rates of functional independence or better recovery compared to performing the

en-US

1:40

NEJM 9 17 2026 Trial of a Maternal Diet Rich in Eggs...

This Week In Medicine ·

2026/09/21

This clinical study investigated whether a mother’s diet during pregnancy and breastfeeding could influence the development of food sensitivities in children with a high genetic risk for allergies. Researchers compared a group of women who consumed large quantities of eggs and peanuts to a control group following a standard diet to see if early allergen exposure via the womb or breast milk offered protection. Despite the intensive dietary intervention, the results showed no significant reduction in

en-US

1:29

NEJM 9 17 2026 Sodium Bicarbonate for Critically Ill...

This Week In Medicine ·

2026/09/21

This clinical study investigated whether administering sodium bicarbonate could improve outcomes for intensive care patients suffering from metabolic acidosis and circulatory shock. Researchers conducted a randomized trial to determine if correcting blood acidity would reduce major adverse kidney events or lower the risk of death for those already requiring blood pressure support. The results demonstrated that there was no significant clinical benefit to using this treatment compared to a placebo,

en-US

1:45

NEJM 9 17 2026 Colonoscopy Intervals and Colorectal...

This Week In Medicine ·

2026/09/21

This study investigates whether extending the time between follow-up screenings for patients who have had high-risk polyps removed compromises their long-term health. By comparing a five-year surveillance interval against the standard three-year recommendation, researchers sought to determine if less frequent monitoring is just as effective at preventing the development of colorectal cancer. The interim findings reveal that waiting longer for a follow-up did not lead to a higher rate of disease,

en-US

1:46

JAMA 9 2026 Low-Voltage Ablation in Persistent Atrial...

This Week In Medicine ·

2026/09/15

This study investigated a more comprehensive surgical strategy for treating persistent atrial fibrillation, a heart rhythm disorder that often resists standard medical interventions. While the traditional approach focuses solely on isolating the pulmonary veins, researchers tested whether targeting specific scarred areas, known as low-voltage zones, would lead to better patient outcomes. The results revealed that patients who received this individualized ablation experienced significantly higher

en-US

1:39

JAMA 9 2026 Adoption of Adjunctive Azithromycin for...

This Week In Medicine ·

2026/09/15

This research study examines how clinical practices evolved following a 2016 discovery that adding the antibiotic azithromycin to standard care significantly lowers the risk of postpartum infections for those undergoing unplanned cesarean sections. By analyzing over a decade of health data, the authors found a substantial increase in the administration of this medication during surgical births in the years following the trial's publication. This shift in medical protocol successfully correlated

en-US

1:31

NEJM 9 10 2026 Complete Revascularization Guided by...

This Week In Medicine ·

2026/09/15

This study explores how doctors can best provide complete revascularization for heart attack patients who have blockages in multiple arteries. By comparing two different diagnostic approaches, the researchers discovered that using functional coronary angiography—which assesses the actual physiological impact of a blockage—significantly outperforms traditional visual inspection. Patients whose treatment was guided by this physiology-based strategyexperienced a notably lower risk of major

en-US

1:49

NEJM 9 10 2026 Obinutuzumab or Tacrolimus in Primary...

This Week In Medicine ·

2026/09/15

This clinical study evaluates the effectiveness of obinutuzumab, a targeted antibody therapy, compared to the traditional drug tacrolimus for treating a specific kidney disorder called primary membranous nephropathy. By tracking patients over two years, researchers discovered that those receiving obinutuzumab were significantly more likely to achieve complete remission, meaning their protein levels normalized while their kidney function remained stable. While both treatments carried similar risks

en-US

1:35

NEJM 9 10 2026 Exa-cel in Children with...

This Week In Medicine ·

2026/09/15

This study investigates a breakthrough gene-editing treatment known as exa-cel, which modifies a patient’s own blood-building cells to stimulate the production of fetal hemoglobin. By targeting children as young as five who suffer from sickle cell disease or transfusion-dependent β-thalassemia, researchers aimed to eliminate the most debilitating symptoms of these genetic disorders. The clinical results were remarkable, as every evaluable participant achieved complete freedom from blood

en-US

1:49

Circulation 8 2026 Bempedoic Acid and First and...

This Week In Medicine ·

2026/09/01

This research study investigates whether bempedoic acid can effectively protect patients with peripheral artery disease (PAD) from severe leg-related complications. By analyzing data from a large clinical trial of individuals who could not tolerate statins, researchers discovered that this medication significantly decreased the risk of both initial and repeat limb events, such as emergency surgeries or severe blockages. The findings emphasize that managing cholesterol is vital for preventing major

en-US

1:26

Circulation 8 2026 Semaglutide and the Inflammatory...

This Week In Medicine ·

2026/09/01

This study explores how the medication semaglutide reduces the risk of major heart-related events by targeting chronic inflammation in patients with cardiovascular disease. Researchers tracked a specific protein marker, hsCRP, and discovered that lowering this indicator significantly improved patient survival regardless of initial weight or cholesterol levels. Crucially, the drug’s ability to dampen the inflammatory responsehappened rapidly and functioned independently of weight loss, suggesting the

en-US

1:35

JAMA August 2026 Methadone vs Buprenorphine-Naloxone...

This Week In Medicine ·

2026/08/26

This study evaluates whether methadone or buprenorphine-naloxone is more effective at preventing mortality among high-risk individuals who have recently survived an opioid overdose. By tracking thousands of patients in Ontario over a several-year period, researchers discovered that those who began a methadone regimen experienced a lower risk of death within the first year compared to those prescribed the alternative. A key factor in this outcome appeared to be treatment retention, as patients stayed

en-US

1:47

JAMA August 2026 Arginine Therapy for Sickle Cell...

This Week In Medicine ·

2026/08/26

This clinical trial investigated whether administering intravenous arginine could effectively alleviate the intense pain crises commonly experienced by young patients with sickle cell disease. Although previous smaller studies suggested that this amino acid might reduce hospital stays and the need for heavy narcotics, this rigorous phase 3 study was halted early for futility after finding no significant benefits. The researchers discovered that arginine was no more effective than a placebo in

en-US

1:41

JAMA August 2026 Predictive Utility of Coronary...

This Week In Medicine ·

2026/08/26

This study examines whether measuring coronary artery calcium (CAC)—a marker of plaque buildup—improves the accuracy of a new medical tool called the PREVENT equations for predicting heart disease risk. Researchers analyzed data from over 6,000 adults to see if adding these heart scans to standard risk assessments helped doctors better categorize patients' 10-year chances of suffering a cardiovascular event. While the results showed only a modest improvementin overall predictive power, the data

en-US

1:51

NEJM 2026 Survodutide Once Weekly for the Treatment...

This Week In Medicine ·

2026/08/24

This study evaluates the effectiveness of survodutide, a novel dual-action medication that targets two different metabolic receptors to promote weight loss in adults living with obesity. By comparing two different dosages against a placebo over a period of 76 weeks, researchers discovered that participants using the drug achieved statistically significant weight reduction compared to those who only received lifestyle counseling. While the treatment proved highly effective for body mass reduction, it

en-US

1:37

NEJM August 2026 Azithromycin for Preschoolers with...

This Week In Medicine ·

2026/08/24

This medical study investigated whether the antibiotic azithromycin could alleviate moderate-to-severe wheezing in preschool-aged children, a condition frequently linked to specific pathogenic bacteria. Researchers conducted a multicenter trial comparing the drug against a placebo, specifically tracking symptom severity scores and hospital stay lengths across both bacterial-positive and bacterial-negative groups. Despite the antibiotic's ability to successfully clear bacteria from the

en-US

1:35

NEJM August 2026 Carbocisteine or Hypertonic Saline...

This Week In Medicine ·

2026/08/24

This clinical study investigated whether two common medications, carbocisteine and hypertonic saline, could reduce the amount of time critically ill patients spend on breathing machines. By analyzing nearly 2,000 participants, researchers determined that neither of these mucoactive agentsshortened the duration of mechanical ventilation compared to standard medical care. Furthermore, the treatments were linked to negative side effects, such as gastrointestinal bleeding and breathing difficulties,

en-US

1:40

NEJM August 2026 Selpercatinib in Early-Stage RET...

This Week In Medicine ·

2026/08/14

This clinical study investigates the effectiveness of selpercatinib, a targeted drug that blocks the RET protein, as a follow-up treatment for patients with early-stage lung cancer who have already undergone surgery or radiation. Researchers conducted a rigorous trial comparing this medication to a placebo to determine if it could prevent the disease from returning in patients with specific genetic markers. The findings demonstrate that selpercatinib significantly extends event-free survival,

en-US

246 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

Healthy Chat

DR ALI BANIHAMOUR

Dingue ‐ RTS

RTS - Radio Télévision Suisse

Vibrantly You® Podcast | Fitness, Nutrition, and Wellness for Pregnancy & Postpartum

Megan Martineau and Caitlin Cipriano

Optimal Health Daily - Fitness and Nutrition

Optimal Living Daily | Dr. Neal Malik